Search Results - bobby+brooke+herrera

3 Results Sort By:
Delivery of exogenous protein/peptide cargoes to the cell cytosol
​ Survival curves of weanling mice immunized with LFn-LACV-Gc or LFn-LACV-N compared with LFn-ZIKV-NS3 and subsequently challenged with LACV Invention Summary: Novel T cell-based vaccine was developed by utilizing a fusion protein by binding a target protein or peptide molecule with transport factor derived from Bacteria. The target protein...
Published: 5/12/2026   |   Updated: 5/12/2026   |   Inventor(s): Bobby Brooke Herrera
Keywords(s):  
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Infectious Disease, Technology Classifications > Vaccine
T cell-based vaccines
​ Survival curves of weanling mice immunized with LFn-LACV-Gc or LFn-LACV-N compared with LFn-ZIKV-NS3 and subsequently challenged with LACV Invention Summary: Novel T cell-based vaccine was developed by utilizing a fusion protein by binding a target protein or peptide molecule with transport factor derived from Bacteria. The target protein...
Published: 5/12/2026   |   Updated: 5/12/2026   |   Inventor(s): Bobby Brooke Herrera
Keywords(s):  
Category(s): Technology Classifications, Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Vaccine
AmpliFAST - PCR in the Palm of Your Hand
​ AmpliFast technology for in home diagnostics. Cassette driven diagnostic kit for fast and early detection of infectious diseases. Invention Summary: There is a need to develop easy-to-use diagnostic kits based on newly discovered enzymes that enable nucleic acid amplification. Rutgers researchers have developed a new technology that...
Published: 5/12/2026   |   Updated: 5/12/2026   |   Inventor(s): Bobby Brooke Herrera
Keywords(s):  
Category(s): Technology Classifications > Diagnostics, Technology Classifications > Healthcare & Life Sciences, Technology Classifications > COVID-19, Technology Classifications > Research Tools